Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate.
about
Spectrum bias--why clinicians need to be cautious when applying diagnostic test studiesScaI atrial natriuretic peptide gene polymorphisms and their possible association with postoperative atrial fibrillation - a preliminary report.Sex- and gender-specific research priorities for the emergency management of heart failure and acute arrhythmia: proceedings from the 2014 Academic Emergency Medicine Consensus Conference Cardiovascular Research Workgroup.Biomarkers of myocardial stress and systemic inflammation in patients who engage in heart failure self-care management.Effects of oral contraceptives on natriuretic peptide levels in women with hypothalamic amenorrhea: a pilot study.Safe use of brain natriuretic protein to rule out the diagnosis of heart failure depends on the selection of cut off value.Effects of transdermal testosterone on natriuretic peptide levels in women: a randomized placebo-controlled pilot studyB-type natriuretic peptide in reversible myocardial ischaemia.Plasma N-terminal pro-brain natriuretic peptide: a prognostic marker in patients with chronic obstructive pulmonary disease.B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide in pediatric patients with pulmonary arterial hypertension.Diagnosis and assessment of the heart failure patient: the cornerstone of effective management.Useulness of B Natriuretic Peptides and Procalcitonin in Emergency Medicine.Differential diagnosis of acute dyspnea: the value of B natriuretic peptides in the emergency department.Plasma midregional pro-atrial natriuretic peptide is associated with blood pressure indices and hypertension severity in adults with hypertensionPro-B-type natriuretic peptide(1-108) circulates in the general community: plasma determinants and detection of left ventricular dysfunction.B-type natriuretic peptide measurement in primary care; magnitude of associations with cardiovascular risk factors and their therapies. Observations from the STOP-HF (St. Vincent's Screening TO Prevent Heart Failure) study.Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender : Results from the PROBE-HF study.Raised plasma N-terminal pro-B-type natriuretic peptide concentrations predict mortality and cardiac disease in end-stage renal disease.Gender aspects in clinical presentation and prognostication of chronic heart failure according to NT-proBNP and the Heart Failure Survival Score.C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.Total plasma proANP increases with atrial dilatation in horses.Impact of atrial fibrillation on NT-proBNP levels in a 75-year-old population.The Correlation of Serum Brain Natriuretic Peptide and Interleukin-6 with Quality of Life Using Chronic Obstructive Pulmonary Disease Assessment Test.Which method is best for an early accurate diagnosis of acute heart failure? Comparison between lung ultrasound, chest X-ray and NT pro-BNP performance: a prospective study.Serum NT-proBNP concentrations in the early phase do not predict the severity of systolic or diastolic left ventricular dysfunction among patients with ST-elevation acute myocardial infarction.Impact of growth hormone (GH) treatment on circulating Nt-proBNP concentrations and on cardiac function in adult GH-deficient patients.The prognostic capacity of B-type natriuretic peptide on cognitive disorder varies by age.Cardiac biomarkers and clinical scores for risk stratification in elderly patients with non-high-risk pulmonary embolism.Accuracy of N-terminal-pro-atrial natriuretic peptide in patients admitted to emergency department.Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: a direct comparison of N-terminal atrial natriuretic peptide, N-terminal brain natriuretic peptide and brain natriuretic peptide.Nt-proANP in plasma, a marker of salt sensitivity, is reduced in type 2 diabetes patients.Relationship between N-terminal pro-B-type natriuretic peptide plasma levels and renal function evaluated with different formulae in older adult subjects admitted because of dyspnea.Determinants of self-measured pulse rate profile in medicated hypertensives: the Jichi Morning Surge-1 (JMS-1) study.Brain natriuretic peptide levels in middle aged subjects with normal left ventricular function in relation to mild-moderate COPD.Non-cardiac determinants of NT-proBNP levels in the elderly: relevance of haematocrit and hepatic steatosis
P2860
Q28292809-4FFA8A06-3C6E-4805-BF75-52669378329AQ33645917-1A708F9A-96E3-4E93-891B-7A88190F0199Q34836591-ECE74438-AAAB-409F-BFD4-1BC9DC3D33C5Q35043024-6F65B4BB-AB5A-499F-B3AF-312CA562403AQ35114062-FC60FA64-9D65-4B98-9A14-73F4618D25F9Q35584481-08C57BF5-EC4F-4F93-86B0-ECC57C818ADAQ35718016-066AC290-7786-4970-B83C-B896161FA221Q35770381-5667C8F7-F2EE-4318-8DDA-9C9A4E2B4FFDQ35919138-B88A3002-F910-4839-B44D-76891AD377C7Q35968889-52D96650-16BF-48CF-ABEA-6700F131A4EFQ36046578-AD7C2E33-175C-4147-9F70-7F2267944334Q37207285-DCF9B372-ADF5-4AFA-96ED-0AB86C196584Q37229555-7AC2AEDB-69B0-40A0-B67A-32EB8FDD181AQ37364330-8272C52A-F2A8-4921-B02E-5D36ECCA6D04Q37591134-2BCA1F79-BCBE-4B04-9627-92A713A36504Q37833104-2188DCDB-F40C-41BF-B804-B914A431E883Q41140893-084C7FC3-010B-4EF1-8733-30571BFCD6E7Q42831299-2DA251EA-E6CE-43DA-9744-42033E2823DEQ44050644-6F221A7F-1F93-4502-8086-0F19C18AD28EQ46061278-70AD7D37-1576-40A5-86EC-45D2EC1FA732Q46632631-C6D43CC2-3314-4E0B-89D7-B8C9B5FB20AFQ47949627-155E4FA1-18FF-4670-8CB7-6F6971C24AE4Q47972423-D0BFF965-19D2-4ACC-9870-06FAA5B545B7Q48166079-F74BF6AC-DD3C-4983-9198-8A65534CAE30Q48305238-0C4DDAE9-5FB6-4DD4-8AD2-A2ABDA60F494Q48441711-41B4B43D-4E43-4355-8DEA-F21F69A45638Q48479424-7AE9213D-5535-43AF-AB19-F361145BB75CQ48495725-242DB4DE-59F1-4ABB-B7FB-246921FB7AAFQ48786011-07673E11-778E-4018-A57D-EA38507A2422Q48881619-47E10A85-97CF-47E0-8B79-0FCA34A47D66Q49042649-522152DA-1E62-40CA-BB50-18D74D698568Q50788583-B6BE2229-4686-4EB9-9C06-5C8F81A827C2Q51705630-5EFEFE21-468A-4643-AD4B-CC259C78D250Q52102359-6730DC45-EF0C-4ED1-B38F-979124B7EDCCQ56997608-6D661AA0-DE56-4B88-A07A-154B51A35774
P2860
Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Reference ranges for natriuret ...... on age, gender and heart rate.
@en
Reference ranges for natriuret ...... on age, gender and heart rate.
@nl
type
label
Reference ranges for natriuret ...... on age, gender and heart rate.
@en
Reference ranges for natriuret ...... on age, gender and heart rate.
@nl
prefLabel
Reference ranges for natriuret ...... on age, gender and heart rate.
@en
Reference ranges for natriuret ...... on age, gender and heart rate.
@nl
P2093
P2860
P1476
Reference ranges for natriuret ...... on age, gender and heart rate.
@en
P2093
Iain B Squire
Joan E Davies
P2860
P304
P356
10.1016/S1388-9842(03)00108-9
P50
P577
2003-10-01T00:00:00Z